These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31836847)

  • 1. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Fang R; Xu F; Shi H; Wu Y; Cao C; Li H; Ye K; Zhang Y; Liu Q; Zhang S; Zhang W; Ye L
    Oncogene; 2020 Mar; 39(11):2290-2304. PubMed ID: 31836847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
    Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
    Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis.
    Nguyen AT; Chia J; Ros M; Hui KM; Saltel F; Bard F
    Cancer Cell; 2017 Nov; 32(5):639-653.e6. PubMed ID: 29136507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
    Huang MJ; Hu RH; Chou CH; Hsu CL; Liu YW; Huang J; Hung JS; Lai IR; Juan HF; Yu SL; Wu YM; Huang MC
    Oncotarget; 2015 Mar; 6(8):5650-65. PubMed ID: 25730904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
    Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
    Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
    Song KH; Park MS; Nandu TS; Gadad S; Kim SC; Kim MY
    Nat Commun; 2016 Dec; 7():13796. PubMed ID: 27982029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
    Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.
    Cascio S; Farkas AM; Hughey RP; Finn OJ
    Oncotarget; 2013 Oct; 4(10):1686-97. PubMed ID: 24072600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GALNT1 Enhances Malignant Phenotype of Gastric Cancer via Modulating CD44 Glycosylation to Activate the Wnt/β-catenin Signaling Pathway.
    Zhang J; Wang H; Wu J; Yuan C; Chen S; Liu S; Huo M; Zhang C; He Y
    Int J Biol Sci; 2022; 18(16):6068-6083. PubMed ID: 36439876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
    Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
    Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1.
    Miwa HE; Gerken TA; Jamison O; Tabak LA
    J Biol Chem; 2010 Jan; 285(2):1208-19. PubMed ID: 19880513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.
    Zhao Y; Li H; Zhang Y; Li L; Fang R; Li Y; Liu Q; Zhang W; Qiu L; Liu F; Zhang X; Ye L
    Cancer Res; 2016 Aug; 76(16):4696-707. PubMed ID: 26980761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.
    Liu BW; Wang TJ; Li LL; Zhang L; Liu YX; Feng JY; Wu Y; Xu FF; Zhang QS; Bao MZ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2019 Apr; 40(4):530-538. PubMed ID: 29925919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
    Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
    Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.
    Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y
    Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ppGalNAc-T family in breast cancer development and progression.
    Yang R; Zhang H; Ma Y; Gong S; Niu J; Ma J; Zhong A
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E144-7. PubMed ID: 27453411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.